• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

鼻脑型毛霉菌病与新型冠状病毒肺炎

Rhinocerebral Mucormycosis and COVID-19 Pneumonia.

作者信息

Alekseyev Kirill, Didenko Lidiya, Chaudhry Bilal

机构信息

Post-Acute Medical Rehabilitation Hospital of Dover, 1240 McKee Road, Dover, DE 19904, USA.

Christiana Care Health System, 4755 Ogletown Stanton Road, Newark, DE 19718, USA.

出版信息

J Med Cases. 2021 Mar;12(3):85-89. doi: 10.14740/jmc3637. Epub 2021 Jan 19.

DOI:10.14740/jmc3637
PMID:33984095
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC8040444/
Abstract

As the coronavirus disease 2019 (COVID-19) pandemic is evolving, more complications associated with COVID-19 are emerging. In this case report, we present a case of rhinocerebral mucormycosis concurrent with COVID-19 pneumonia in a 41-year-old man with a history of type 1 diabetes mellitus (T1DM). COVID-19 pneumonia was diagnosed with reverse transcription-polymerase chain reaction (RT-PCR). He was promptly treated with steroids and hydroxychloroquine, as this was the recommended regional COVID-19 practice patterns at the time. He was treated with intravenous (IV) fluids and an insulin drip for his diabetic ketoacidosis (DKA), cefepime and IV abelcet, along with three surgical debridements for the rhinocerebral mucormycosis. The pneumonia resolved during the course of his stay in the hospital. With prompt diagnosis and treatment of rhinocerebral mucormycosis, the patient was cleared for discharge and was instructed to complete his course of treatment with coumadin and IV abelcet at home. Saprophytic fungi cause rhinocerebral mucormycosis, a rare opportunistic infection of the sinuses, nasal passages, oral cavity and brain. It usually occurs in patients with poorly controlled diabetes mellitus or those who are immunocompromised, which is again demonstrated in this case report. In the setting of COVID-19 pneumonia and an underlying condition, healthcare professionals should act promptly. In cases where mucormycosis infection is suspected, a prompt diagnosis and treatment should be started because of the angioinvasive character and rapid disease progression that contribute to the severity of the mucormycosis infection.

摘要

随着2019冠状病毒病(COVID-19)大流行的演变,与COVID-19相关的更多并发症正在出现。在本病例报告中,我们介绍了一名41岁1型糖尿病(T1DM)病史男性并发COVID-19肺炎的鼻脑毛霉菌病病例。通过逆转录聚合酶链反应(RT-PCR)诊断为COVID-19肺炎。由于当时这是推荐的地区性COVID-19治疗模式,他立即接受了类固醇和羟氯喹治疗。他因糖尿病酮症酸中毒(DKA)接受了静脉输液和胰岛素滴注治疗,使用了头孢吡肟和静脉注射两性霉素B脂质体,同时对鼻脑毛霉菌病进行了三次手术清创。肺炎在他住院期间得到缓解。经过对鼻脑毛霉菌病的及时诊断和治疗,患者获准出院,并被指示在家中完成华法林和静脉注射两性霉素B脂质体的疗程。腐生真菌引起鼻脑毛霉菌病,这是一种罕见的鼻窦、鼻腔、口腔和脑部机会性感染。它通常发生在糖尿病控制不佳或免疫功能低下的患者中,本病例报告再次证明了这一点。在COVID-19肺炎和潜在疾病的情况下,医护人员应迅速采取行动。在怀疑毛霉菌病感染的病例中,由于其血管侵袭性和疾病进展迅速,会导致毛霉菌病感染的严重性,应迅速进行诊断和治疗。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/c684/8383581/97771ec99b63/jmc-12-085-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/c684/8383581/97771ec99b63/jmc-12-085-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/c684/8383581/97771ec99b63/jmc-12-085-g001.jpg

相似文献

1
Rhinocerebral Mucormycosis and COVID-19 Pneumonia.鼻脑型毛霉菌病与新型冠状病毒肺炎
J Med Cases. 2021 Mar;12(3):85-89. doi: 10.14740/jmc3637. Epub 2021 Jan 19.
2
Diabetic ketoacidosis and coronavirus disease 2019-associated mucormycosis: a case report.糖尿病酮症酸中毒与 2019 冠状病毒病相关毛霉菌病:病例报告。
J Med Case Rep. 2022 Oct 31;16(1):400. doi: 10.1186/s13256-022-03594-2.
3
When Worlds Collide: An Interesting Case of Rhinocerebral Mucormycosis Exacerbated by COVID-19 and Diabetic Ketoacidosis Complicated by Intraorbital Hematoma.当世界碰撞:一例因新冠病毒病和糖尿病酮症酸中毒加重、并发眶内血肿的鼻脑型毛霉菌病的有趣病例
Cureus. 2022 Jan 13;14(1):e21203. doi: 10.7759/cureus.21203. eCollection 2022 Jan.
4
Invasive rhinocerebral mucormycosis: Imaging the temporal evolution of disease in post COVID-19 case with diabetes: A case report.侵袭性鼻脑型毛霉菌病:COVID-19后合并糖尿病病例中疾病的影像学时间演变:一例报告
World J Radiol. 2023 Jul 28;15(7):234-240. doi: 10.4329/wjr.v15.i7.234.
5
Rhinocerebral mucormycosis in a patient with type 1 diabetes presenting as toothache: a case report from Himalayan region of India.一名1型糖尿病患者以牙痛为表现的鼻脑型毛霉菌病:来自印度喜马拉雅地区的病例报告
BMJ Case Rep. 2013 Oct 30;2013:bcr2013200811. doi: 10.1136/bcr-2013-200811.
6
Treatment of rhinocerebral mucormycosis with intravenous interstitial, and cerebrospinal fluid administration of amphotericin B: case report.静脉、间质及脑脊液注射两性霉素B治疗鼻脑型毛霉菌病:病例报告
Neurosurgery. 1998 Mar;42(3):644-8; discussion 648-9. doi: 10.1097/00006123-199803000-00037.
7
New-Onset Pediatric Diabetes Complicated By Diabetic Ketoacidosis and Invasive Rhinocerebral Mucormycosis With Internal Carotid Artery Occlusion.新诊断儿童糖尿病伴糖尿病酮症酸中毒和侵袭性鼻-颅底毛霉菌病并颈内动脉闭塞。
J Emerg Med. 2022 Jan;62(1):95-100. doi: 10.1016/j.jemermed.2021.07.024. Epub 2021 Sep 9.
8
Rhinocerebral Mucormycosis: An Emerging Threat in the Era of COVID-19.鼻脑型毛霉菌病:COVID-19时代的一种新出现的威胁。
Cureus. 2022 Aug 16;14(8):e28057. doi: 10.7759/cureus.28057. eCollection 2022 Aug.
9
Rhinocerebral mucormycosis: pathways of spread.鼻脑型毛霉菌病:传播途径
Eur Arch Otorhinolaryngol. 2005 Nov;262(11):932-8. doi: 10.1007/s00405-005-0919-0. Epub 2005 May 13.
10
COVID-19-Associated Mucormycosis in a Tertiary Care Hospital in India: A Case Series.印度一家三级护理医院中与新冠病毒病相关的毛霉菌病:病例系列
Cureus. 2022 Aug 11;14(8):e27906. doi: 10.7759/cureus.27906. eCollection 2022 Aug.

引用本文的文献

1
Midface defects caused by mucormycosis with a new classification: a retrospective study.毛霉菌病所致面中部缺损的新分类:一项回顾性研究
Arch Craniofac Surg. 2025 Aug;26(4):147-153. doi: 10.7181/acfs.2025.0002. Epub 2025 Aug 20.
2
Craniofacial Involvement of Mucormycosis: A Single-Center Experience of 57 Cases From Shiraz, Iran.毛霉菌病的颅面部累及:来自伊朗设拉子的57例单中心经验
Can J Infect Dis Med Microbiol. 2025 Jul 30;2025:4780569. doi: 10.1155/cjid/4780569. eCollection 2025.
3
Management challenges of postpartum rhinocerebral mucormycosis following spontaneous vaginal delivery in a resource-constraint setting: A case report and review of literature.

本文引用的文献

1
Bronchopleural fistula development in the setting of novel therapies for acute respiratory distress syndrome in SARS-CoV-2 pneumonia.新型疗法治疗新型冠状病毒肺炎急性呼吸窘迫综合征时支气管胸膜瘘的发生情况
Radiol Case Rep. 2020 Nov;15(11):2378-2381. doi: 10.1016/j.radcr.2020.09.026. Epub 2020 Sep 18.
2
Mucormycosis treatment: Recommendations, latest advances, and perspectives.毛霉病治疗:推荐意见、最新进展和展望。
J Mycol Med. 2020 Sep;30(3):101007. doi: 10.1016/j.mycmed.2020.101007. Epub 2020 Jun 20.
3
Global guideline for the diagnosis and management of mucormycosis: an initiative of the European Confederation of Medical Mycology in cooperation with the Mycoses Study Group Education and Research Consortium.
资源受限环境下自然阴道分娩后鼻脑型毛霉菌病的管理挑战:一例病例报告及文献综述
Int J Surg Case Rep. 2025 Jan;126:110834. doi: 10.1016/j.ijscr.2025.110834. Epub 2025 Jan 3.
4
The Study of Clinical Profile of Patients With Mucormycosis During COVID-19 Pandemic in Tertiary Care Hospital.三级护理医院中COVID-19大流行期间毛霉菌病患者的临床特征研究
Cureus. 2023 Oct 15;15(10):e47065. doi: 10.7759/cureus.47065. eCollection 2023 Oct.
5
COVID-19-Associated Rhino-Orbital Mucormycosis in a Tertiary Health Care Center in Odisha, India.印度奥里萨邦一家三级医疗中心的新冠肺炎相关鼻眶毛霉菌病
Cureus. 2023 Aug 20;15(8):e43811. doi: 10.7759/cureus.43811. eCollection 2023 Aug.
6
Mucormycosis and Its Upsurge During COVID-19 Epidemic: An Updated Review.《COVID-19 大流行期间的毛霉菌病及其激增:最新综述》。
Curr Microbiol. 2023 Aug 17;80(10):322. doi: 10.1007/s00284-023-03430-w.
7
A Case Report of Invasive Mucormycosis in a COVID-19 Positive and Newly-Diagnosed Diabetic Patient.1例新冠病毒检测呈阳性且新诊断为糖尿病患者的侵袭性毛霉病病例报告
J Educ Teach Emerg Med. 2023 Jul 31;8(3):V10-V13. doi: 10.21980/J81M1G. eCollection 2023 Jul.
8
Clinicoradiological Profile of COVID-19-Associated Rhino-Orbital Cerebral Mucormycosis with a Focus on Computed Tomography: A Clinical Case Series and Review.COVID-19 相关的 Rhino-Orbital Cerebral Mucormycosis 的临床放射学特征:一项临床病例系列研究和综述。
Am J Trop Med Hyg. 2023 Jul 24;109(3):600-607. doi: 10.4269/ajtmh.22-0298. Print 2023 Sep 6.
9
Mucormycosis: An Epidemic Complicating the COVID-19 Pandemic.毛霉菌病:一种使新型冠状病毒肺炎大流行复杂化的流行病。
Oman Med J. 2023 May 31;38(3):e511. doi: 10.5001/omj.2023.16. eCollection 2023 May.
10
COVID-19 and Mucormycosis of Orofacial Region: A Scoping Review.2019冠状病毒病与口面部毛霉菌病:一项范围综述
Cureus. 2023 Apr 22;15(4):e37984. doi: 10.7759/cureus.37984. eCollection 2023 Apr.
全球毛霉病诊断和管理指南:欧洲医学真菌学会联合会与真菌感染研究组教育和研究联盟合作开展的一项倡议。
Lancet Infect Dis. 2019 Dec;19(12):e405-e421. doi: 10.1016/S1473-3099(19)30312-3. Epub 2019 Nov 5.
4
Rhino-oculo Cerebral Mucormycosis Resistant to Amphotericin B in a Young Patient with Diabetic Ketoacidosis.一名患有糖尿病酮症酸中毒的年轻患者中对两性霉素B耐药的鼻眼脑毛霉菌病
Cureus. 2019 Mar 22;11(3):e4295. doi: 10.7759/cureus.4295.
5
Breaking the Mold: A Review of Mucormycosis and Current Pharmacological Treatment Options.打破常规:毛霉病及当前药物治疗选择综述
Ann Pharmacother. 2016 Sep;50(9):747-57. doi: 10.1177/1060028016655425. Epub 2016 Jun 15.
6
Diabetes and mucormycosis: a complex interplay.糖尿病与毛霉菌病:复杂的相互作用。
Diabetes Metab. 2012 Jun;38(3):193-204. doi: 10.1016/j.diabet.2012.01.002. Epub 2012 Mar 3.
7
The Deferasirox-AmBisome Therapy for Mucormycosis (DEFEAT Mucor) study: a randomized, double-blinded, placebo-controlled trial.去铁酮-两性霉素 B 脂质体治疗毛霉病(DEFEAT Mucor)研究:一项随机、双盲、安慰剂对照试验。
J Antimicrob Chemother. 2012 Mar;67(3):715-22. doi: 10.1093/jac/dkr375. Epub 2011 Sep 20.